LPA(2) Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction.
Pei J, Cai L, Wang F, Xu C, Pei S, Guo H, Sun X, Chun J, Cong X, Zhu W, Zheng Z, Chen X.
Circ Res. 2022 Aug 19;131(5):388-403. doi: 10.1161/CIRCRESAHA.122.321036. Epub 2022 Aug 3.
PMID:35920162
Compact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.
Lussier G, Evans AJ, Houston I, Wilsnack A, Russo CM, Vietor R, Bedocs P.
Cureus. 2024 Oct 3;16(10):e70789. doi: 10.7759/cureus.70789. eCollection 2024 Oct.
PMID:39493181
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
Blanco-Domínguez R, de la Fuente H, Rodríguez C, Martín-Aguado L, Sánchez-Díaz R, Jiménez-Alejandre R, Rodríguez-Arabaolaza I, Curtabbi A, García-Guimaraes MM, Vera A, Rivero F, Cuesta J, Jiménez-Borreguero LJ, Cecconi A, Duran-Cambra A, Taurón M, Alonso J, Bueno H, Villalba-Orero M, Enríquez JA, Robson SC, Alfonso F, Sánchez-Madrid F, Martínez-González J, Martín P.
J Clin Invest. 2022 Nov 1;132(21):e152418. doi: 10.1172/JCI152418.
Targeting SETD7 Rescues Diabetes-Induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin-3G.
Mohammed SA, Gorica E, Albiero M, Karsai G, Mengozzi A, Caravaggi CM, Ambrosini S, Masi S, Vinci MC, Dzemali O, Spinetti G, Rajagopalan S, El-Osta A, Pelisek J, Ruschitzka F, Fadini GP, Costantino S, Paneni F.
Diabetes. 2025 Jun 1;74(6):969-982. doi: 10.2337/db24-0997.
PMID:40014026
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular disease.
Bhalla SR, Wahid M, Amartey JO, Zawia A, Riu F, Gao Y, Agrawal J, Lynch AP, Machado MJC, Hawtrey T, Kikuchi R, Green KR, Teboul L, Allen C, Blackley Z, Rajaji K, Batson J, Harper SJ, Oltean S, Amoaku W, Benest AV, Morris JC, Braithwaite B, Bates DO.
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H490-H504. doi: 10.1152/ajpheart.00564.2024. Epub 2025 Jun 30.
PMID:40588360
Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular dysfunction and impairment of cardiac function after myocardial infarction.
Molitor M, Bayo-Jimenez MT, Hahad O, Witzler C, Finger S, Garlapati VS, Rajlic S, Knopp T, Bieler TK, Aluia M, Wild J, Lagrange J, Blessing R, Rapp S, Schulz A, Kleinert H, Karbach S, Steven S, Ruf W, Wild P, Daiber A, Münzel T, Wenzel P.
Cardiovasc Res. 2023 Jun 13;119(6):1416-1426. doi: 10.1093/cvr/cvad021.
PMID:36702626
Disrupting circadian control of peripheral myogenic reactivity mitigates cardiac injury following myocardial infarction.
Cardiovasc Res. 2023 Jun 13;119(6):1403-1415. doi: 10.1093/cvr/cvac174.
PMID:36418171
Endothelial cell (EC)-specific Ctgf/Ccn2 expression increases EC reprogramming and atherosclerosis.
Li F, Kumar S, Pokutta-Paskaleva A, Kang DW, Kim C, Raykin J, Omojola V, Hoffmann C, Zhao F, Teichmann M, Park C, In Baek K, Sanchez Marrero G, Ma J, Yanagisawa H, Leask A, Timmins L, Cui X, Sutliff R, Gleason RL Jr, Jo H, Brewster LP.
Matrix Biol. 2025 Apr;136:102-110. doi: 10.1016/j.matbio.2025.01.003. Epub 2025 Jan 14.
PMID:39818254
Aryl Hydrocarbon Receptor Nuclear Translocator in Vascular Smooth Muscle Cells Is Required for Optimal Peripheral Perfusion Recovery.
Borton AH, Benson BL, Neilson LE, Saunders A, Alaiti MA, Huang AY, Jain MK, Proweller A, Ramirez-Bergeron DL.
J Am Heart Assoc. 2018 Jun 1;7(11):e009205. doi: 10.1161/JAHA.118.009205.